1-15 of 15
Sanjal H. Desai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort

Sanjal H. Desai, Reid W. Merryman, Harsh Shah, Levi D. Pederson, Susan M. Geyer, Nivetha Ganesan, Tiffany Chang, Tamer Othman, Ayo S Falade, Gunjan L. Shah, Urshila Durani, Kelsey Baron, Shin Yeu Ong, Steve M Ansell, Philippe Armand, Siddharth Iyengar, Ivana Micallef, Alison Moskowitz, Alex F. Herrera, Robert Stuver, Matthew Genyeh Mei
Journal: Blood
Blood (2023) 142 (Supplement 1): 182.
https://doi.org/10.1182/blood-2023-179573
Published: 2023
Journal Articles

Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Eric McLaughlin, Pallawi Torka, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Natalie S. Grover, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 3061.
https://doi.org/10.1182/blood-2023-181056
Published: 2023
Journal Articles

Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents

Ayo S Falade, Robert A. Redd, Harsh Shah, Kelsey Baron, Siddharth Iyengar, Sanjal H. Desai, Stephen M Ansell, Ivana Micallef, Adrienne Nedved, Nivetha Ganesan, Tiffany Chang, Gunjan L. Shah, Robert Stuver, Alison Moskowitz, Matthew Genyeh Mei, Tamer Othman, Shin Yeu Ong, Alex F. Herrera, Philippe Armand, Reid W. Merryman
Journal: Blood
Blood (2023) 142 (Supplement 1): 3062.
https://doi.org/10.1182/blood-2023-182318
Published: 2023
Journal Articles

Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant

Kelsey Baron, Esther Drill, Nivetha Ganesan, Reid W. Merryman, Matthew G. Mei, Robert Stuver, Sanjal H. Desai, Ayo S Falade, Siddharth Iyengar, Ivana Micallef, Lay She Ng, Ellie Casper, Natasha Galasso, Randa Tao, Savita Dandapani, Andrea Ng, Joachim Yahalom, Alex F. Herrera, Alison Moskowitz, Harsh Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4436.
https://doi.org/10.1182/blood-2023-173470
Published: 2023
Journal Articles

Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers

Timothy Voorhees, Natalie S. Grover, Eric McLaughlin, Jorge A Florindez, Tamara K. Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish R. Ayyappan, Lauren Kelly Shea, Matthew J Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal H. Desai, Praveen Ramakrishnan Geethakumari, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 900.
https://doi.org/10.1182/blood-2023-182385
Published: 2023
Journal Articles

Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies

Robert Stuver, Esther Drill, Nivetha Ganesan, Kelsey Baron, Ellie Casper, Tiffany Chang, Sanjal H. Desai, Ayo S Falade, Natasha Galasso, Alex F. Herrera, Matthew G. Mei, Reid W. Merryman, Ivana Micallef, Harsh Shah, Alison Moskowitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3069.
https://doi.org/10.1182/blood-2023-182143
Published: 2023
Journal Articles

Treatment Patterns and Outcomes for Patients with Classic Hodgkin Lymphoma (cHL) and Cardiomyopathy with Low Ejection Fraction (EF): Real-World Evidence (RWE) from 16 US Academic Centers

Kaitlin Annunzio, Eric McLaughlin, Timothy Voorhees, Lauren Kelly Shea, Nuttavut Sumransub, Ashley Rose, Adam J Olszewski, Neil Bailey, Krish Patel, Tamara K. Moyo, Farrukh T. Awan, Gulrayz Ahmed, Natalie S. Grover, Adam Adika, Erica L Andres, Muhammad Salman Faisal, Beth Christian, Jacob Anna, Steven M. Bair, Nicholas Kendsersky, Colin Thomas, Pallawi Torka, Jakub Svoboda, Jordan S Carter, Mehdi Hamadani, Hayder Saeed, Sanjal H. Desai, Andrew M Evens, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 382.
https://doi.org/10.1182/blood-2023-182389
Published: 2023
Journal Articles

Improved Survival of R/R Double Hit/Triple Hit Lymphoma in the Era of CD19 Chimeric Antigen T Cell (CART) Therapy

Sanjal H. Desai, Nuttavut Sumransub, Rich Evans, Marcus P Watkins, Reem Karmali, Gaurav Goyal, Mitchell E. Hughes, Arushi Khurana, Francisco J. Hernandez-Ilizaliturri, Joanna Zurko, Ayesha Hassan, Haris Hatic, Imran A. Nizamuddin, Andrew M Evens, Andrea Carolina Anampa-Guzmán, Yi Lin, Iris Isufi, Mehdi Hamadani, Saurabh A Rajguru, Naveena Lall, Aung M. Tun, Brian T. Hill, Deborah M. Stephens, Paolo F. Caimi, Daniel A. Ermann, Brad S. Kahl, Daniel J. Landsburg, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 308.
https://doi.org/10.1182/blood-2023-183001
Published: 2023
Journal Articles

Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era

Sanjal H Desai, Raphael Mwangi, Yucai Wang, Umar Farooq, Eric Mou, Andrew L. Feldman, Sergei Syrbu, Susan L. Slager, Grzegorz S. Nowakowski, Matthew J. Maurer, Neil E. Kay, Thomas M. Habermann, Brian K. Link, Carrie A. Thompson, James R. Cerhan
Journal: Blood
Blood (2022) 140 (Supplement 1): 1934–1936.
https://doi.org/10.1182/blood-2022-165207
Published: 2022
Journal Articles

Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival

Charlotte B Wagner, Daniel A. Ermann, Ken Boucher, Adrienne N. Nedved, Ivana N. Micallef, Sanjal H Desai, Haris Hatic, Gaurav Goyal, Erin Zacholski, Amanda Fegley, Audrey M. Sigmund, David A. Bond, Courtney Samuels, Manali K. Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Kira MacDougall, Azra Borogovac, Sridevi Rajeeve, Suchitra Sundaram, Kalub Fedak, Dipenkumar Modi, Elizabeth Travers, Sabarish Ayyappan, Nitin Chilakamarri, Elizabeth A Brem, Deborah M. Stephens, Boyu Hu, Lindsey A. Fitzgerald, Harsh Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 9390–9392.
https://doi.org/10.1182/blood-2022-159001
Published: 2022
Journal Articles

Outcomes of Relapsed Refractory Double Hit Lymphoma: A Multicenter Observational Cohort

Sanjal H Desai, Marcus P. Watkins, Reem Karmali, Gaurav Goyal, Mitchell Hughes, Arushi Khurana, Francisco Hernandez-Ilizaliturri, Nuttavut Sumransub, Joanna Zurko, Imran A. Nizamuddin, Haris Hatic, Daniel A Landsburg, Andrea Anampa-Guzman, Mehdi Hamadani, Yi Lin, Iris Isufi, Aung M Tun, Brian T. Hill, Deborah M. Stephens, Paolo F Caimi, Daniel A. Ermann, Brad S. Kahl, Grzegorz S. Nowakowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 10391–10393.
https://doi.org/10.1182/blood-2022-159725
Published: 2022
Journal Articles

Novel Salvage Regimens Lead to Better Response and Survival in Relapsed Refractory Classic Hodgkin Lymphoma after Autologous Stem Cell Transplant

Sanjal H Desai, Michael A Spinner, Kevin A. David, Veronika Bachanova, Gaurav Goyal, Jacques Azzi, Kathleen Dorritie, Vaishalee P. Kenkre, Cheryl Chang, Sally Arai, Brendon Fusco, Nuttavut Sumransub, Haris Hactic, Uroosa Ibrahim, Elyse Harris, Matthew J. Maurer, KC Rappazzo, Victor M. Orellana-Noia, Catherine S. Diefenbach, Saba Raya, Grzegorz S. Nowakowski, Ranjana Advani, Ivana N. Micallef
Journal: Blood
Blood (2021) 138 (Supplement 1): 878.
https://doi.org/10.1182/blood-2021-149880
Published: 2021
Journal Articles

PET2 Response Associated with Survival in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Results of Two Independent Prospective Cohorts

Sanjal H Desai, Levi D. Pederson, Betsy Laplant, Raphael Mwangi, Matthew J. Maurer, Jason R. Young, William R. Macon, Rebecca L. King, Yucai Wang, James R. Cerhan, Andrew L. Feldman, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood
Blood (2021) 138 (Supplement 1): 2508.
https://doi.org/10.1182/blood-2021-151276
Published: 2021
Journal Articles

DA-EPOCH-R Has Comparable Outcomes in De Novo and Transformed Diffuse Large B Cell Lymphoma

Sanjal H Desai, MD, Mansi Chaturvedi, Rumaisa Hameed, Valentina Baez Sosa, MD, Aarthi Shenoy, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-140607
Published: 2020
Journal Articles

Lenalidomide/RCHOP (R2CHOP) Produces High Response Rates and Overall Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma- Results from MC078E

Sanjal H Desai, MD, Betsy Laplant, MS, William R. Macon, MD, Rebecca L. King, MD, Yucai Wang, MDPhD, David J. Inwards, MD, Ivana Micallef, MD, Patrick B. Johnston, Luis F. Porrata, MD, Stephen M. Ansell, MD PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-141298
Published: 2020